BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TED-A9 (A9-DPC) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of TED-A9 (A9-DPC)\, from ClinicalTrials.gov
  estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06477744-1709@assetmemo.bio
DTSTAMP:20261121T005424Z
DTSTART;VALUE=DATE:20290207
DTEND;VALUE=DATE:20290208
SUMMARY:TED-A9 (A9-DPC): Phase na readout est. (NCT06477744)
DESCRIPTION:TED-A9 (A9-DPC)\, phase na\, Parkinson's Disease.\nStudy: Long 
 Term Follow-up of Patients With Parkinson's Disease Who Had Administered o
 f A9-DPC in SB-PD-001 Study\nEstimated primary completion: 7 February 2029
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/ted-a9-a9-dpc#upcom
 ing-events\nRegistry record: https://clinicaltrials.gov/study/NCT06477744
URL:https://assetmemo.bio/drug/ted-a9-a9-dpc#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
